Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4(+) T cells. [electronic resource]
Producer: 19991019Description: 336-41 p. digitalISSN:- 0340-7004
- Abatacept
- Animals
- Antibodies, Monoclonal -- pharmacology
- Antigens, CD
- Antigens, Differentiation -- pharmacology
- B7-1 Antigen -- immunology
- CD28 Antigens -- immunology
- CD4-Positive T-Lymphocytes -- immunology
- CD40 Antigens -- immunology
- CD40 Ligand
- CD8-Positive T-Lymphocytes -- immunology
- CTLA-4 Antigen
- Colonic Neoplasms -- immunology
- Female
- Graft Rejection -- immunology
- Hemagglutinins, Viral -- genetics
- Immunization
- Immunoconjugates
- Lymphocyte Depletion
- Mammary Neoplasms, Experimental -- immunology
- Membrane Glycoproteins -- immunology
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Mice, SCID
- Neoplasm Transplantation -- immunology
- Recombinant Fusion Proteins -- immunology
- Specific Pathogen-Free Organisms
- Transfection
- Tumor Cells, Cultured -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.